Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Total Debt: 2024

Historic Total Debt for Kura Oncology (KURA) over the last 1 years, with Dec 2024 value amounting to $9.5 million.

  • Kura Oncology's Total Debt rose 2.12% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year increase of 2.12%. This contributed to the annual value of $9.5 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Kura Oncology reported Total Debt of $9.5 million as of FY2024.
  • In the past 5 years, Kura Oncology's Total Debt ranged from a high of $9.5 million in FY2024 and a low of $9.5 million during FY2024.
  • In the last 1 years, Kura Oncology's Total Debt had a median value of $9.5 million in 2024 and averaged $9.5 million.